about
Leukocyte activity is altered in a ground based murine model of microgravity and proton radiation exposureParticle therapy for non-small cell lung tumors: where do we stand? A systematic review of the literatureDevelopment of a golden beam data set for the commissioning of a proton double-scattering system in a pencil-beam dose calculation algorithm.Evidence for radiation-induced disseminated intravascular coagulation as a major cause of radiation-induced death in ferretsIncreased intracranial pressure in mini-pigs exposed to simulated solar particle event radiationPencil beam scanning dosimetry for large animal irradiationOrally Administered Fructose Increases the Numbers of Peripheral Lymphocytes Reduced by Exposure of Mice to Gamma or SPE-like Proton Radiation.Comparison of changes over time in leukocyte counts in Yucatan minipigs irradiated with simulated solar particle event-like radiation.Broad-spectrum antibiotic or G-CSF as potential countermeasures for impaired control of bacterial infection associated with an SPE exposure during spaceflight.Effects of a granulocyte colony stimulating factor, Neulasta, in mini pigs exposed to total body proton irradiationTheoretical Benefits of Dynamic Collimation in Pencil Beam Scanning Proton Therapy for Brain Tumors: Dosimetric and Radiobiological Metrics.Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer.Technical Note: Validation of halo modeling for proton pencil beam spot scanning using a quality assurance test pattern.Technical Note: A treatment plan comparison between dynamic collimation and a fixed aperture during spot scanning proton therapy for brain treatmentA benchmarking method to evaluate the accuracy of a commercial proton monte carlo pencil beam scanning treatment planning system.A novel technique for measuring the low-dose envelope of pencil-beam scanning spot profiles.Optimization of the modelling of longitudinal dose distributions for double-scattered proton beams in a commercially-available treatment planning system.Consensus Guidelines for Implementing Pencil-Beam Scanning Proton Therapy for Thoracic Malignancies on Behalf of the PTCOG Thoracic and Lymphoma Subcommittee.Synthetic Secoisolariciresinol Diglucoside (LGM2605) Protects Human Lung in an Ex Vivo Model of Proton Radiation Damage.A study of the beam-specific interplay effect in proton pencil beam scanning delivery in lung cancer.Experimental characterization of two-dimensional pencil beam scanning proton spot profiles.First Ever Use of Proton Stereotactic Body Radiation Therapy Delivered with Curative Intent to Bilateral Synchronous Primary Renal Cell Carcinomas.Development and clinical implementation of a universal bolus to maintain spot size during delivery of base of skull pencil beam scanning proton therapy.3D printer generated thorax phantom with mobile tumor for radiation dosimetry.Risk of major cardiac events following adjuvant proton versus photon radiation therapy for patients with thymic malignancies.First Clinical Investigation of Cone Beam Computed Tomography and Deformable Registration for Adaptive Proton Therapy for Lung Cancer.Proposed linear energy transfer areal detector for protons using radiochromic film.Experimentally validated pencil beam scanning source model in TOPAS.Implementation of an improved dose-per-MU model for double-scattered proton beams to address interbeamline modulation width variability.Predicted Rate of Secondary Malignancies Following Adjuvant Proton Versus Photon Radiation Therapy for Thymoma.Use of a novel two-dimensional ionization chamber array for pencil beam scanning proton therapy beam quality assurance.Experimental characterization of two-dimensional spot profiles for two proton pencil beam scanning nozzles.Prospective study of proton beam radiation therapy for adjuvant and definitive treatment of thymoma and thymic carcinoma: Early response and toxicity assessmentClinical significance of pretreatment tumor growth rate for locally advanced non-small cell lung cancerThe use of directional interstitial sources to improve dosimetry in breast brachytherapyProton therapy coverage for prostate cancer treatmentImage guidance based on prostate position for prostate cancer proton therapyDose-volume comparison of proton therapy and intensity-modulated radiotherapy for prostate cancerDosimetric uncertainty in prostate cancer proton radiotherapyValidation and clinical implementation of an accurate Monte Carlo code for pencil beam scanning proton therapy
P50
Q21132559-B2B0A246-E849-4786-B885-CA8425242581Q27023426-B9C4E5FB-150B-4435-9032-6B2DD5CE3020Q30847404-AA32A0FC-CF47-4B1F-A39F-7B76F741C0BDQ33413129-CF0AEA08-C418-4F68-AA9E-560A70918A60Q34200001-A47C9AC0-6DA6-4943-A5E6-402177C46321Q34366532-B7F1903C-6C22-4B0A-9D2F-FD7903167990Q34406266-613B4452-8DEB-4621-A125-FF292C6EC939Q35169453-56E0D999-DDB2-435D-93C1-B5A8244F7C23Q35203060-58359177-9A27-4055-A215-A52C4019736CQ35482320-9F301162-86AD-4833-9CD4-D2A35DD16D03Q38650898-AD8C6877-0F29-49BA-96F7-7FA21F2F749EQ38693035-5C6459D4-23A7-43C6-A3BC-933E39E16225Q40585844-4754B0B0-E5C2-4299-BAED-E8C534ACF016Q41823028-0CE0C7FB-C7AA-4455-AFB1-EF6147EC65A7Q43663702-9F236EDA-CB16-4D72-A582-44276296C6B5Q43733341-48E28E19-E53F-49EC-BB0E-28EFC8A6C90DQ45720576-AD1F5C24-E95B-4F4C-885F-7DCB487696ABQ46211644-1FDBA618-BB58-4894-A832-1E5278993B96Q46251814-FF6A3A84-AE25-4B97-9603-0C482B8ADA3FQ46390759-1FA18194-515B-49E9-99E8-3ED3054481BAQ46690344-A2AF7D6B-B4CD-466C-9B05-4454C4C7EE11Q47162224-B787EA0B-37E9-4208-8CE3-ED61D6239015Q47438257-DC944DF1-ACE3-42EF-9452-3E4D41567CE4Q47627054-122C8FF1-42D0-4FBA-8102-D00F7C9414C1Q48365205-92091EE7-0486-4F6B-9471-1E37FC681DB6Q50665162-DA5AD149-FD80-4BC6-913F-14D97B2F6E19Q50921499-55E981D4-10EF-4317-B4B9-3BAD770D34E1Q51019726-AF3CA294-3248-4FC3-8AC2-9AE710948491Q51081754-B43F9D92-EA75-4B4C-A73B-1336A486E1FFQ51795552-95C49DA6-9A8A-400F-8FF1-3A6D6077297CQ53175482-76E4E082-93E4-4F33-BB8C-A1E91091F72EQ53647279-A851095A-AC1D-4A96-8AB5-0295E1C408C7Q61635315-13022105-C0BB-4D8D-BC3B-E50BA08BC5FEQ64073728-F0A244F9-D947-4DB2-84CB-E0478F342E03Q80755458-B79B881F-35DF-4C02-8C4A-7759B5FFB036Q80976358-4AC59372-DC3F-419D-AD98-F4AE0828F883Q81255470-1DBC2413-40E8-432C-BFC9-D9F1884EA10DQ81371416-6A4649FF-2277-475A-9978-35EDAA9F1333Q82905166-09060547-E185-41DD-964F-28191BF03313Q90603560-14368808-C63D-4348-96D4-A32BFF1C2AA3
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Liyong Lin
@ast
Liyong Lin
@en
Liyong Lin
@es
Liyong Lin
@nl
Liyong Lin
@sl
type
label
Liyong Lin
@ast
Liyong Lin
@en
Liyong Lin
@es
Liyong Lin
@nl
Liyong Lin
@sl
prefLabel
Liyong Lin
@ast
Liyong Lin
@en
Liyong Lin
@es
Liyong Lin
@nl
Liyong Lin
@sl
P106
P1153
23100305500
P31
P3835
liyong-lin
P496
0000-0002-0820-8063
P569
2000-01-01T00:00:00Z